Deal marks first recreational contract for the
Company
MARKHAM, ON, Feb. 14, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF)
("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP
certified cannabis producer, today announced that it has signed a
Letter of Intent ("LOI") with Société des alcools du Québec ("SAQ")
to supply the Province of Quebec
with a guaranteed volume of high quality adult recreational-use
cannabis.
Under the terms of the LOI, MedReleaf will supply the
Quebec market with a minimum of
8,000 kilograms of cannabis products per year.
"We are proud to be working with SAQ, one of the largest
purchasers of alcohol in the world, to ensure the safe, reliable,
and responsible distribution of adult-used cannabis," said
Neil Closner, CEO of MedReleaf. "Our
capacity expansion in Bradford is
on track, and we look forward to delivering an assortment of our
award-winning cannabis products and brands to the Province of
Quebec in the first year of this
agreement."
As Canada's leading supplier of
premium medical cannabis, MedReleaf is recognized for its
commitment to cultivating consistent, safe, high-quality cannabis.
At the voter-driven 2017 Lift Canadian Cannabis Awards, MedReleaf
led the industry by winning LP of the year and placing in 10
different categories including first place awards in several
product categories: Top Indica Flower, Top CBD Flower, Top High THC
Flower, and Top High CBD Oil.
About MedReleaf Corp.
Voted Top Licensed Producer at the 2017 Lift Canadian Cannabis
Awards, MedReleaf is an R&D-driven company dedicated
to innovation, operational excellence and the production of
top-quality cannabis. Sourced from around the world and
carefully cultivated in one of two state of the art ICH-GMP and ISO
9001 certified facilities in Ontario, the Company
delivers a variety of premium products for the global medical
market and is committed to serving the therapeutic needs of its
medical patients and providing a compelling product assortment for
the adult-use recreational consumer.
For more information on MedReleaf, its products, research
and how the company is helping patients #livefree, please visit
MedReleaf.com or follow @medreleaf
SOURCE MedReleaf Corp.